260 related articles for article (PubMed ID: 26172047)
1. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
[TBL] [Abstract][Full Text] [Related]
2. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
3. Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.
Balsano R; Kruize Z; Lunardi M; Comandatore A; Barone M; Cavazzoni A; Re Cecconi AD; Morelli L; Wilmink H; Tiseo M; Garajovà I; van Zuylen L; Giovannetti E; Piccirillo R
Cells; 2022 Aug; 11(17):. PubMed ID: 36078078
[TBL] [Abstract][Full Text] [Related]
4. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer.
Dasgupta A; Gibbard DF; Schmitt RE; Arneson-Wissink PC; Ducharme AM; Bruinsma ES; Hawse JR; Jatoi A; Doles JD
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2215095120. PubMed ID: 37585460
[TBL] [Abstract][Full Text] [Related]
5. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
6. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
[TBL] [Abstract][Full Text] [Related]
8. The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells.
Wang F; Liu H; Hu L; Liu Y; Duan Y; Cui R; Tian W
BMC Cancer; 2018 Apr; 18(1):360. PubMed ID: 29609556
[TBL] [Abstract][Full Text] [Related]
9. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
[TBL] [Abstract][Full Text] [Related]
11. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
[TBL] [Abstract][Full Text] [Related]
12. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
Yakovenko A; Cameron M; Trevino JG
World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678
[TBL] [Abstract][Full Text] [Related]
13. Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.
Delitto D; Judge SM; Delitto AE; Nosacka RL; Rocha FG; DiVita BB; Gerber MH; George TJ; Behrns KE; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Oncotarget; 2017 Jan; 8(1):1177-1189. PubMed ID: 27901481
[TBL] [Abstract][Full Text] [Related]
14. Modeling Human Cancer-induced Cachexia.
Talbert EE; Cuitiño MC; Ladner KJ; Rajasekerea PV; Siebert M; Shakya R; Leone GW; Ostrowski MC; Paleo B; Weisleder N; Reiser PJ; Webb A; Timmers CD; Eiferman DS; Evans DC; Dillhoff ME; Schmidt CR; Guttridge DC
Cell Rep; 2019 Aug; 28(6):1612-1622.e4. PubMed ID: 31390573
[TBL] [Abstract][Full Text] [Related]
15. Cancer cachexia: molecular mechanism and pharmacological management.
Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
[TBL] [Abstract][Full Text] [Related]
16. SIRT1-NOX4 signaling axis regulates cancer cachexia.
Dasgupta A; Shukla SK; Vernucci E; King RJ; Abrego J; Mulder SE; Mullen NJ; Graves G; Buettner K; Thakur R; Murthy D; Attri KS; Wang D; Chaika NV; Pacheco CG; Rai I; Engle DD; Grandgenett PM; Punsoni M; Reames BN; Teoh-Fitzgerald M; Oberley-Deegan R; Yu F; Klute KA; Hollingsworth MA; Zimmerman MC; Mehla K; Sadoshima J; Tuveson DA; Singh PK
J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32441762
[TBL] [Abstract][Full Text] [Related]
17. Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia.
Olson B; Norgard MA; Levasseur PR; Zhu X; Marks DL
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1312-1332. PubMed ID: 34231343
[TBL] [Abstract][Full Text] [Related]
18. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
Elife; 2020 May; 9():. PubMed ID: 32391790
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
Shukla SK; Dasgupta A; Mulder SE; Singh PK
Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
[TBL] [Abstract][Full Text] [Related]
20. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression.
das Neves W; Alves CR; de Almeida NR; Guimarães FL; Ramires PR; Brum PC; Lancha AH
Life Sci; 2016 Oct; 163():11-22. PubMed ID: 27575705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
